Melhores Cancro do estômago em estágio 2 médicos em Israel - TOP-19 médicos

O Prof. Merimsky chefia a Unidade de Oncologia de Tecidos Moles e Ossos no Sourasky Medical Center, com décadas de experiência especializada em cancro gástrico.

• Professor Associado de Oncologia na Universidade de Tel-Aviv
• Formação de especialização (Fellowship) no Institut Gustave Roussy, em Paris
• Membro da Faculdade de Sarcoma da ESMO e da ASCO
• Várias publicações sobre os resultados do tratamento do cancro

A Dra. Pelles Sharon é especialista em cirurgia de câncer de estômago no Sourasky Medical Center (Ichilov), com perícia em tratamentos avançados como HIPEC e imunoterapia.

• Realizar cirurgias complexas de câncer de estômago, incluindo o procedimento de Whipple
• Pioneirar a quimioterapia intraperitoneal hipertérmica (HIPEC) para casos agressivos
• Oferecer opções de imunoterapia como Keytruda para tratamento direcionado
• Liderar pesquisas clínicas sobre as atitudes de pacientes oncológicos em relação a ensaios clínicos

Ele lidera um Centro de Prevenção de Cancro dedicado no Sourasky Medical Center de Tel Aviv, com foco na deteção precoce e no tratamento de cancros gastrointestinais.

• Mais de 30 anos de experiência especializada em oncologia do trato gastrointestinal
• Diretor do Centro Integrado de Prevenção de Cancro – uma das principais instalações oncológicas de Israel
• Autor de mais de 300 artigos de investigação sobre prevenção de cancro e terapia genética
• Realizar trabalhos de investigação significativos no NewYork-Presbyterian Center nos EUA
• Membro de sociedades internacionais importantes, como a European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Líder da Iniciativa Nacional de Medicina Genómica de Israel – o Dr. Raphael especializa-se em perfil genómico avançado para o tratamento personalizado do cancro gástrico no Sourasky Medical Center.

• Professor de Oncologia Médica com vasta experiência na liderança de ensaios clínicos
• Especialista em biópsias líquidas e perfil genómico abrangente
• Investigador Principal (PI) de múltiplos estudos inovadores de imunoterapia e quimioterapia
• Membro da ESMO, IASLC e outras prestigiadas sociedades de oncologia
• Vencedor de múltiplos prémios de excelência em ensino e investigação

O Dr. Wolf chefia a Divisão de Oncologia Médica do Sourasky Medical Center – um importante hospital universitário israelense com vasta experiência em cuidados oncológicos complexos.

• Especializar-se em oncologia médica e medicina interna
• Dominar o inglês para pacientes internacionais
• Possuir graduação pela Universidade Ben Gurion
• Adquirir vasta experiência clínica em unidades médicas do exército

Chefe do Departamento de Cirurgia Colorretal no Sourasky Medical Center e é um dos principais especialistas em procedimentos abdominais complexos.

• Mais de 20 anos de experiência cirúrgica
• Especialista em cirurgia aberta e minimamente invasiva
• Especializado em técnicas avançadas, como o procedimento de Whipple

O Dr. Stepfansky chefia a unidade de internação oncológica no principal hospital de Tel Aviv, Ichilov, e participa de ensaios clínicos para os tratamentos mais recentes.

• Mais de 20 anos de experiência em medicina interna e oncologia
• Dirigir os cuidados oncológicos de internação no Sourasky Medical Center
• Investigador principal para estudos clínicos de fase 1-3
• Concluir treinamento extensivo no Hospital Ichilov em Tel Aviv

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

O Dr. Alexander Beny lidera o Serviço de Malignidade Gastrointestinal no Rambam Medical Center, especializando-se no tratamento do cancro do estômago.

• Oncologista certificado com vasta formação em oncologia médica e radioterapia
• Diretor do Serviço de Malignidade Gastrointestinal no Rambam Medical Center
• Fluente em inglês e hebraico para pacientes internacionais
• Formação especializada concluída em técnicas modernas de braquiterapia

A Professora Tamar Jablonski-Perec chefia a oncologia no Hadassah Medical Center, com formação no Sloan-Kettering Cancer Center em Nova Iorque.

• Chefiar o Instituto de Oncologia desde 1994
• Especializar-se no tratamento do cancro da mama
• Professora no Departamento de Oncologia da Universidade Hebraica
• Membro de comunidades internacionais de oncologia
• Premiada com uma bolsa da Hadassah Medical School